nimustine has been researched along with Anaplastic Ependymoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asari, S; Doi, A; Fujiwara, T; Furuta, T; Matsumoto, K; Moriya, Y; Nakasone, S; Nishimoto, A; Ohnishi, R; Tabuchi, K | 1 |
Muraoka, K | 1 |
Kochi, M; Kuratsu, J; Mihara, Y; Seto, H; Takaki, S; Uemura, S; Ushio, Y | 1 |
Maruo, K; Nakamura, O; Nomura, K; Takakura, K; Ueyama, Y | 1 |
Himuro, H; Inoue, N; Kaetsu, I; Kitamura, K; Kubo, O; Sakairi, M; Tajika, T; Tajika, Y; Tohyama, T; Yoshida, M | 1 |
Kanno, M; Katakura, R; Kitahara, M; Mori, T; Niizuma, H; Suzuki, J; Wada, T; Yoshimoto, T | 1 |
6 other study(ies) available for nimustine and Anaplastic Ependymoma
Article | Year |
---|---|
[Combination chemotherapy of brain tumors with ACNU and 5-FU].
Topics: Astrocytoma; Biological Products; Brain Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Ependymoma; Fluorouracil; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Picibanil | 1983 |
[ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Ependymoma; Female; Glioma; Humans; Injections, Intra-Arterial; Kinetics; Lymphoma; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Phenobarbital | 1983 |
Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Drug; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Half-Life; Humans; Injections, Intraventricular; Injections, Spinal; Male; Medulloblastoma; Meningeal Neoplasms; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Nimustine; Prohibitins; Subarachnoid Space; Survival Rate | 1993 |
[Antineoplastic effect of Hu-IFN-beta and other anticancer drugs on malignant brain tumors in athymic nude mice].
Topics: Animals; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Ependymoma; Glioblastoma; Glioma; Interferon Type I; Mice; Mice, Inbred BALB C; Mice, Nude; Nimustine; Nitrosourea Compounds; Vincristine | 1985 |
[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Implants; Dysgerminoma; Ependymoma; Fluorouracil; Glioma; Humans; Medulloblastoma; Methylmethacrylates; Mitomycin; Mitomycins; Neoplasms, Germ Cell and Embryonal; Nimustine; Nitrosourea Compounds; Teratoma | 1986 |
[Results of combined radiochemotherapy of intracranial ependymoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Female; Fluorouracil; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; Tegafur | 1987 |